cell and gene therapy world


Why Phacilitate

We believe that through strong partnerships and collaboration, anything can be achieved.


“The whole is greater than the sum of its parts.” - Aristotle

Phacilitate is a specialist in the organisation of exclusive events for leaders from the pharma and biotech communities. Our philosophy is simple - to deliver the ultimate in strategic knowledge exchange and networking through flawless, personalised service.

Our team is focused on just a handful of events each year – our Cell & Gene Therapy World and Immuno-Oncology Frontiers (Miami, January); Cell & Gene Therapy Europe and Immuno-Oncology Frontiers (Berlin, September); and Big Data in Precision Medicine (Washington, DC, October). This level of specialisation means that we have closer links with, and spend more time listening to, the industry we serve than any other conference organiser, aided by the input of our Advisory Boards. Coming up next: SIG Automation (The Grove, London), Trade Mission: Navigating Asia (Tokyo - Seoul), Phacilitate Leaders Europe ( Lancaster Royal Hotel, London). 

Our Commitments:

1. Phacilitate events are committed to advanced therapy. It is the future of healthcare.

2. We are collaborative. We will work with you if it’s for the benefit of the advanced therapy eco-system.

3. We have and will continue making bold moves if it’s for the benefit of the industry.

4. Phacilitate provides flawless customer service and goes the extra mile.

5. Anything we do for our customer is because we want to not because we have to.

6. Our team builds trust through honesty. We create loyalty by giving value first.

7. Phacilitate events share the same goals as our customers, we will never run a ‘me too’ event to make money.

8. We are accessible. We want you to meet us at our events and at others. We create unforgettable experiences.

9. We are knowledge sharers! We want to give you a better understanding of the market.

10. We always know what’s coming next through our 365 dedication to advanced therapies and continuous research. And we tell you about it first.

If you would like to find out more about the way we deliver value to our clients, or would like to make any suggestions for new topic areas or formats you would like to see us address,

please contact Michael Adeniya, Event Directoron +44 (0)20 7384 7951 michael@phacilitate.co.uk

Be part of a Phacilitate event

  • "The event reflected the fantastic growing enthusiasm around cell and gene therapy, including small and large companies, investors and regulators. It was great to see everyone so engaged and so positive. The event really gives you the “pulse” of what is happening right now in cell and gene therapy."
    Anne-Virginie Eggimann,
  • “Great program, great people, great venue.”
    Klaus Kühlcke
    Managing Director, EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.”
    Nathalie Clement
    Associate Director, Powell Gene Therapy Center, University of Florida
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • "It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives."
    Kurt Gielen
    Acquisition & Business Development Manager, BioMedical Materials, Chemelot Campus B.V.
  • “Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.”
    Steven Goodman
    Director, Strategy and Engagement, GSK